Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Two honest points up front
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Petersburg today
Combination protocols (very effective) PT-141 + PDE-5 Inhibitor PT-141: 0.51 mg SQ Tadalafil: 510 mg PO Use together for synergistic effect Common side effects Use PT-141 for immediate performance Shockwave for long-term vascular remodeling Common side effects (dose-dependent) Nausea (most common) Facial flushing Headache Mild BP elevation (transient) Injection site irritation How to reduce nausea Start low (0.5 mg) Avoid fatty meals pre-dose Consider ondansetron 4 mg PRN (if needed Contraindications / cautions Who Should Avoid PT-141 Uncontrolled hypertension Significant cardiovascular instability History of severe nausea with melanocortins Avoid daily chronic use (on-demand)
Helps support fat metabolism and oxidation
US$ 21.05
US$ 27.49
US$ 28.08
US$ 21.92
US$ 20.81
US$ 29.85
US$ 25.16
US$ 20.17
